Thomas Vanicek Selected Research

Thomas Vanicek Research Topics

6	Treatment-Resistant Depressive Disorder 01/2023 - 02/2017
5	Major Depressive Disorder (Major Depressive Disorders) 01/2024 - 02/2017
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2017 - 12/2014
2	Mood Disorders (Mood Disorder) 11/2022 - 01/2019
2	Depressive Disorder (Melancholia) 05/2019 - 02/2017
2	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 04/2015
1	Borderline Personality Disorder (Personality Disorders, Borderline) 11/2022
1	Atrophy 01/2022
1	Disease Progression 01/2021
1	Pain (Aches) 01/2019
1	Seasonal Affective Disorder 01/2018
1	Bipolar Disorder (Manic Depressive Psychosis) 03/2017
1	Mental Disorders (Mental Disorder) 01/2016
1	Schizophrenia (Dementia Praecox) 04/2015

4	Ketamine FDA LinkGeneric 11/2022 - 04/2015
4	Antidepressive Agents (Antidepressants)IBA 11/2022 - 02/2017
3	Monoamine Oxidase (MAO)IBA 09/2020 - 01/2018
3	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 03/2016 - 12/2014
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2024 - 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2023
1	EsketamineIBA 11/2022
1	Serotonin AgentsIBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	gamma-Aminobutyric Acid (GABA)IBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Harmine (Telepathine)IBA 05/2019
1	Escitalopram FDA Link 01/2019
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2019
1	5-HT1A Serotonin ReceptorIBA 01/2019
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2017
1	3' Untranslated Regions (3' UTR)IBA 03/2016
1	5' Untranslated Regions (5' UTR)IBA 03/2016
1	IGF-I-IGFBP-3 complex FDA Link 03/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2015
1	N-Methylaspartate (NMDA)IBA 04/2015
1	morpholineIBA 12/2014